Nestomin 2.5 Injection containing Neostigmine is used for the management of neuromuscular disorders and reversal of neuromuscular blockade after surgery. It helps in restoring muscle function and improving nerve-muscle communication.
Neostigmine works by inhibiting acetylcholinesterase, which increases acetylcholine levels and enhances neuromuscular transmission effectively.
The injection is widely used in hospitals, surgical units, and critical care settings, leading to consistent demand in institutional healthcare segments.
With increasing demand for surgical and critical care medicines, this product offers strong business potential for distributors and institutional suppliers. Its essential role in operative care, steady hospital demand, and specialized neuro application make it a reliable product for consistent sales and growth in the critical care segment.
Some patients may experience abdominal cramps, excessive salivation, nausea, sweating, slow heart rate, or muscle twitching. Rarely, severe cholinergic reactions, breathing difficulty, or allergic reactions may occur and require immediate medical attention.
Nestomin 2.5 Injection is indicated for the treatment of myasthenia gravis, postoperative urinary retention, paralytic ileus, and reversal of non-depolarizing neuromuscular blockade after surgery. It helps improve muscle strength, restore normal muscle function, and support recovery from anesthesia-related muscle paralysis.
This injection should be administered under strict medical supervision with appropriate monitoring. Use cautiously in patients with asthma, cardiac disorders, epilepsy, or gastrointestinal obstruction. Atropine may be kept available to manage excessive cholinergic effects if needed.
Store in a cool, dry place below 25°C, protected from light. Do not freeze. Keep out of reach of children.